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The coronary vasomotor response to the cold pressor test 
was studied with use of quantitative coronary angiography 
in 32 patients without evidence of coronary artery disease 
and 55 patients with such disease; in a subset of 22 patients 
(9 with normal coronary arteries and 13 with coronary 
artery disease), the effects of the cold pressor test were 
compared with the effects of the endothelium-dependent 
vasodilator acetylcholine with simultaneous intracoronary 
Doppler flow velocity measurements to assess the influence 
of endothelial dysfunction. The cold pressor test induced 
vasodilation of 8.9 f 5.7% in all 77 analyzed vessel 
segments of the group with normal arteries (p < 0.01). In 
contrast, in patients with coronary artery disease, the 52 
analyzed stenotic segments were constricted by -12.1 f 
9.5% (p < O.Ol), the 57 analyzed vessel segments with 
luminal irregularities were constricted by -8.9 f 5.2% 
(p < 0.01) and 40 (85%) of 47 angiographically normal 
segments also were constricted by -7.0 + 4.9% (p < 0.05). 
Preserved vasodilating capability was demonstrated by 
intracoronary nitroglycerin in ah analyzed segments. In 
nine patients with normal coronary arteries, the analyzed 
vessel segments were dilated in response to both the cold 
pressor test and intracoronary acetylcholine by 10.9 f 
5.4% and 13.4 + 4.7%, respectively. In contrast, in all 13 
patients with coronary artery disease, vasoconstriction of 
identical vessel segments by -9.1 f 3.75% and -23 f 
10.4%, respectively, was observed after both the cold 
pressor test and intracoronary acetylcholine. Intracoronary 
propranolol did not significantly affect either the vasodila- 
tive response in 11 normal coronary arteries (11.3 + 4.4% 
before and 8.6 f 4.3% after beta-blockade) or the vaso- 
constrictor response in 8 atherosclerotic coronary arteries 
(-11.4 A 4.6% before and -14.6 + 5.3% after beta- 
blockade). 
The dilation of normal and the constriction of athero- 
sclerotic coronary arteries with cold pressor testing exactly 
mirror the response to the endothelium-dependent dilator 
acetylcholine. Endothelial dysfunction in coronary athero- 
sclerosis resulted in a loss of normal dilator function and 
permitted vasoconstrictor responses to sympathetic stimu- 
lation. Thus, coronary vasomotion of large epicardial ar- 
teries in response to sympathetic stimulation by the cold 
pressor test in humans is intimately related to the integrity 
of endothelial function. 
(J Am Co11 Cardiol1989;14:1181-90) 
In vitro studies (1) have demonstrated the important role of 
the endothelium in modulating the responsiveness of the 
underlying vascular smooth muscle. Furchgott and Zawad- 
ski (2) showed that the ability of acetylcholine to dilate blood 
vessels depended on an intact endothelial cell layer. The 
discovery that the endothelium plays a critical role in medi- 
ating vasodilation to a variety of stimuli (3-5) prompted the 
widely accepted hypothesis that damaged endothelial cells 
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may predispose blood vessels to episodes of spasm (6). 
However, relatively little attention has been paid to the role 
of the endothelium in mediating vasomotion by adrenergic 
mechanisms. Recent experimental studies (7) in intact dogs 
have demonstrated that the vasodilator response to epineph- 
rine (a mixed alpha- and beta-adrenergic agonist) is reversed 
to a vasoconstrictor response after removal of the endothe- 
lium, thereby indicating that the endothelium mediates the 
dilation in response to adrenergic stimulation in large canine 
iliac arteries. 
Sympathetic stimulation by the cold pressor test in hu- 
mans was recently shown (8) to dilate normal coronary 
arteries but constrict atherosclerotic coronary arteries in 
vivo, thus suggesting that normal vasodilation is replaced by 
paradoxic vasoconstriction in the presence of atherosclero- 
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sis. On the basis of these results, it was hypothesized that 
endothelial dysfunction present in atherosclerosis may result 
in a loss of dilator function and permit constrictor responses 
to sympathetic stimulation. 
The present study was designed to assess the importance 
of the functional integrity of the endothelium in modulating 
coronary vasomotion in response to cold pressor testing. For 
this purpose, the effects of cold pressor test-induced sympa- 
thetic stimulation on coronary vasomotor tone were deter- 
mined in a large series of patients with no evidence of 
coronary artery disease or with an early stage of coronary 
artery disease indicated by minor irregularities without he- 
modynamically significant stenosis. To specifically evaluate 
the role of intact endothelial function in mediating the 
vasomotor response to sympathetic stimulation, cold pres- 
sor test-induced vasomotion was compared with the effects 
of endothelium-dependent vasodilator acetylcholine. 
Methods 
Classification of patients. Eighty-seven patients undergo- 
ing routine diagnostic cardiac catheterization were studied. 
These patients were classified into two groups on the basis of 
their history and the presence or absence of atherosclerosis 
on the diagnostic angiogram. 
Group I: normal control group. Thirty-two patients with 
angiographically normal coronary arteries served as control 
subjects. Patients with a history of arterial hypertension 
(defined as systolic blood pressure >I50 mm Hg and diastol- 
ic blood pressure >90 mm Hg) or the presence of left 
ventricular hypertrophy, diabetes mellitus and hypercholes- 
terolemia were excluded from the normal control group. 
Total serum cholesterol values in these patients ranged from 
148 to 213 mg/lOO ml (mean + SD 179 2 14) and triglyceride 
levels ranged from I I I to 147 mg/lOO ml (mean 131 t 8). The 
majority of these 32 patients were studied because of atyp- 
ical chest pain; 3 patients (all of them women) had an 
abnormal thallium exercise test and 4 had intermittent left 
bundle branch block as the cause for referral for diagnostic 
angiography. The mean age of these patients was 45.2 years; 
there were 17 women and I5 men. All subjects had angio- 
graphically normal, smooth coronary arteries without lumi- 
nal irregularities and no evidence of segmental wall motion 
abnormalities on left ventricular cineangiography. 
Group II: patients with coronary artery disease. Fifty-five 
patients were classified as having coronary artery disease. 
Seventeen of these patients had luminal irregularities in at 
least one major coronary artery, with no focal stenosis 
>50% diameter narrowing on diagnostic coronary angiogra- 
phy. Mean total serum cholesterol level in these patients was 
231 ? 35 mg/lOO ml (range 154 to 316); high density lipopro- 
tein (HDL) cholesterol was 50 + 12 mg/lOO ml (range 29 to 
81, n = I I), and triglycerides were 179 5 32 mg/lOO ml (range 
122 to 288). Twenty-six patients had one vessel disease 
(defined as >50% diameter narrowing), eight patients had 
two vessel disease and four patients had three vessel dis- 
ease. Total serum cholesterol in these patients with at least 
one coronary lesion with >50% diameter narrowing was 
246 f 39 mg/lOO ml (range 158 to 335) HDL cholesterol was 
45 ? 21 mg/lOO ml (range 23 to 89) and triglycerides were 
183 -t 42 mg/lOO ml (range 122 to 279). Ten subjects were 
women, 45 were men: their mean age was 54.3 years. 
Patients with unstable angina, recent myocardial infarction 
or clinical evidence of heart failure were excluded. 
Written informed consent was obtained from all patients 
before the studies. Study protocols were approved by the 
Ethical Committee of the University of Freiburg. 
Study design. Vasoactive therapy was discontinued at 
least 24 h before cardiac catheterization. No patient received 
a beta-adrenergic blocking agent within 48 h before the 
study. Diagnostic coronary angiography was performed by a 
standard percutaneous femoral approach using the Judkins 
technique. The cold pressor test was performed r5 min after 
the control angiogram. For cold pressor testing, the patient’s 
hand and forearm were immersed in ice water for 90 s. Heart 
rate and aortic pressure were continuously measured, and 
serial hand injections of nonionic contrast material (UI- 
travist, Schering AG) into the left coronary artery were 
performed at control and at the end of the cold pressor test 
(immediately after removal of the forearm from ice water). 
After a 5 min recovery period, 0.3 mg of nitroglycerin was 
injected into the left coronary artery to assess the vasodila- 
tory capability of the coronary arteries, and a final angio- 
gram was obtained. 
Studies with acetylcholine. In 9 subjects from the normal 
control group and I3 patients with coronary artery disease, 
the vasomotor effects of the cold pressor test and acetylcho- 
line were compared. Of the 13 patients with coronary artery 
disease, 3 had >50% luminal narrowing of the left anterior 
descending artery, 5 had luminal irregularities with no focal 
stenosis >50% and 4 had an angiographically completely 
normal left anterior descending artery, but evidence of 
atherosclerosis elsewhere in the coronary system. 
Ten minutes after cold pressor testing, acetylcholine was 
selectively infused into the left anterior descending artery 
through a Doppler catheter. Increasing dosages were used to 
achieve estimated final blood concentrations in the coronary 
bed of lo-‘, lo-’ and 10dh M (assuming a blood flow of 80 
ml/min) at an infusion rate of 1 mlimin, lasting 3 min for each 
concentration. For this purpose, an additional 5,000 U of 
heparin was given intravenously, and an 8F guiding catheter 
(Schneider) was introduced into the left main coronary 
artery. A 3F Monorail-Doppler catheter (Schneider) with a 
20 MHz pulsed Doppler crystal was advanced into the left 
anterior descending artery by means of a 0.014 in (0.036 cm) 
guidewire. The Doppler catheter was carefully positioned to 
obtain a stable flow velocity signal. Before the Doppler 
catheter was introduced into the guiding catheter, flow 
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velocity recordings were referenced to zero and calibrated. 
Continuous phasic and mean coronary flow velocity mea- 
surements and serial contrast injections were performed 
during control study, at the end of cold pressor testing. at 
recontrol study, at the end of each acetylcholine infusion 
period and after intracoronary nitroglycerin, which was 
injected 5 min after the end of the acetylcholine infusion. 
Studies with intracoronary beta-blockade. To evaluate the 
role of beta-adrenergic receptors in mediating the coronary 
vasomotor response, 11 subjects from the normal control 
group and 8 with coronary artery disease underwent two 
serial cold pressor tests before and after the intracoronary 
administration of propranolol. Right atrial pacing at 10 
beatsimin above the intrinsic heart rate was performed 
throughout the study in the initial four subjects. However, 
transient termination of atrial pacing in these patients did not 
reveal any changes in heart rate or aortic blood pressure 
after the administration of intracoronary propranolol com- 
pared with the hemodynamic values before propranolol. 
Therefore, atrial pacing was not performed in the remaining 
15 patients undergoing the beta-blockade study. In nine of 
these patients (four with normal coronary arteries and five 
with coronary artery disease), left anterior descending artery 
blood flow velocity was continuously measured by the 
Doppler catheter, as described. After the initial cold pressor 
test, I mg of propranolol was infused into the left main 
coronary artery over 2 min, and a second cold pressor test 
was performed. Coronary angiograms were obtained under 
control conditions, at the end of the initial cold pressor test, 
at recontrol study after a 5 rnin recovery period, 2 min after 
the intracoronary infusion of 1 mg of propranolol, at the end 
of the second cold pressor test under beta-blockade and after 
intracoronary nitroglycerin, which was injected 5 min after 
the second cold pressor test. 
Quantitative coronary angiography. Coronary angiogra- 
phy was performed with use of a simultaneous biplane 
multidirectional isocentric radiographic system (Siemens 
Bicor). Coronary arteries under study were positioned near 
the isocenter. and special care was taken to avoid overlap- 
ping of coronary segments. Biplane cineangiograms were 
recorded at a rate of 25 frames/s. The study angiograms were 
examined by three investigators, and coronary arteries were 
classified as smooth. irregular or stenotic by a consensus 
decision before analysis. Measurements of coronary seg- 
ments were made in several vessels. but only one segment 
per vessel was analyzed. Coronary segments were measured 
at the site of stenosis in stenotic vessels, at the site of luminal 
irregularities in minimally diseased vessels and in a well 
defined region of the angiographically smooth-appearing 
vessels. For quantitative analysis, end-diastolic tine frames 
were videodigitized and stored in the image analysis system 
(Mipron I, Kontron electronics) in a 512 x 5 12 matrix with 
an eight bit gray scale. With use of the 12 cm field of view. 
the resulting pixel density was 7.3 pixels/mm. The geometric 
resolution of the X-ray imaging chain was >4 line pairs/mm. 
Automatic vessel segment contoar detection was per- 
formed by a geometric edge differentiation technique similar 
to the method described by Reiber et al. (9). In brief, after 
interactive delineation of a centerline within the vessel 
segment to be measured, the computer automatically gener- 
ates a number of scanlines perpendicular to the centerline. 
The first and second derivative function of the densograms 
along each scanline are then computed, and the contour 
point is defined as 60% of the distance between the extrema 
of the first and second derivatives. With use of the detected 
contour points, the computer then automatically generates a 
refined centerline of the vessel segment, and the edge 
detection algorithm is repeated. Each individual scanline is 
smoothed by a second order polynomial fit, and smoothing 
of the contour is obtained by averaging three neighboring 
scanlines. Calculation of the exact radiologic magnification 
factor of the measured segment is used to scale the data from 
pixels to millimeters, as previously described (10). 
This technique was previously validated in phantom 
studies. The accuracy and precision of quantitative angio- 
graphic measurements were determined from the analysis of 
tine films of a Plexiglas block with precision-drilled models 
of coronary arteries with diameters of I, 2, 3 and 3.5 mm 
filled with contrast medium and filmed under 10 cm of water. 
The accuracy of the contour detection technique was defined 
by the average difference of the computed results with the 
true values. and the precision was defined by the pooled 
standard deviations of the differences. These phantom mea- 
surements revealed an accuracy of 3.5 t 1.7%~ (mean t I 
SD, n = 80 measurements) and a precision of 2.4 + 1.1%. 
The reproducibility of the measurements (repeated analysis 
of the cineangiograms by one analyst) revealed a coefficient 
of variation of I .4 2 0.6%. Interobserver variability associ- 
ated with the computer analysis was I.7 t 0.7% (coefficient 
of variation). 
Six to 8 mm segments from angiographically normal 
vessels and vessels with luminal irregularities were mea- 
sureti. A series of diameter measurements was obtained for 
each scanline for the length of the arterial segment, dis- 
played in graphic form showing diameter versus segment 
length and the mean diameter value was calculated. Tapered 
vessel segments were not evaluated. In stenotic segments, 
the narrowest portion of the stenosis was measured. When- 
ever possible, measurements were performed in both views 
of the biplane images. In both normal and irregular seg- 
ments. the diameter values of both views were averaged; in 
stenotic segments, the narrowest diameter from one of the 
two views was chosen. Only single plane analysis was 
performed for those coronary segments demonstrating over- 
lap with other parts of the coronary tree in one view. 
Reproducibility of serial measurements. Anatomic land- 
marks were used to reproduce the regions of interest to be 
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measured spatially in repeated measurements to assess serial 
changes. The reproducibility of serial measurements of the 
same coronary segment during repeated contrast injection 
was assessed in the present study. For this purpose, in 10 of 
the patients receiving selective infusion of acetylcholine into 
the left anterior descending artery, a segment in the midpor- 
tion of the left circumflex artery was measured at control 
study and at the end of each of the three acetylcholine 
infusion periods. Thus, the coefficients of variation comprise 
not only the natural variability of the diameter of a coronary 
segment measured at sequential time points without inter- 
posed interventions (because acetylcholine was infused only 
into the left anterior descending artery, not into the circum- 
flex artery), but also the intraobserver variability associated 
with repeated measurements of the same coronary segment 
in serial cineangiographic recordings. In addition, potential 
contrast material effects on the diameters of coronary arter- 
ies caused by serial injections would have been detected in 
this way. The mean coefficient of variation was 2.2 f 1.1% 
(n = 40 measurements). Moreover, there were no significant 
directional changes in the measured diameters after serial 
injections of contrast material. Thus, a 5 min recovery 
period after the injection of 5 to 8 ml of nonionic contrast 
material into the left coronary system proved to be sufficient 
for avoiding any effects of the contrast material itself on the 
diameter of epicardial coronary arteries during serial studies. 
Estimation of coronary blood flow. For rough estimation 
of directional changes in coronary blood flow, the mean 
Doppler-derived blood flow velocity was multiplied by the 
computed cross-sectional area of the vessel at the site of the 
Doppler crystal. The cross-sectional area was calculated 
from biplane views, assuming an elliptical shape of the 
vessel. Because the injection of contrast material into the 
coronary circulation resulted in the typical biphasic response 
of coronary blood flow velocity with an initial decrease 
followed by an increase in flow velocity as a result of the 
hyperemic effects of the contrast material, the mean blood 
flow velocity immediately before the contrast injection was 
used for estimation of coronary blood flow. 
Statistical analysis. All data are expressed as mean values 
k SD. Statistical comparisons were made by analysis of 
variance for repeated measures followed by the Student- 
Newman-Keuls test. Changes in hemodynamics and vessel 
diameters during the cold pressor test before and after 
infusion of propranolol were analyzed by Student’s paired t 
test. Statistical significance was assumed if a null hypothesis 
could be rejected at the 0.05 probability level. 
Results 
Group II: patients with coronary artery disease (Fig. 1B). 
In the 55 patients with coronary artery disease, a total of 52 
stenotic segments were analyzed. All 52 stenotic segments 
were constricted by -12.1 ? 9.5% in response to sympa- 
thetic stimulation. The mean minimal stenosis diameter 
decreased from 1.23 k 0.11 mm at control study to 1.08 + 
0.13 mm at the end of cold pressor testing (p < 0.01). 
Intracoronary nitroglycerin resulted in an increase in mini- 
mal stenosis diameter to 1.40 2 0.14 mm (p < O.Ol), 
reflecting an increase of 14.3 + 12.9% compared with control 
vessel diameter. 
Systemic bemodynamics during sympathetic stimulation A total of 57 segments of coronary arteries with minor 
(Table 1). Sympathetic stimulation by the cold pressor test luminal irregularities were analyzed in the 55 group II 
increased heart rate and systolic blood pressure in all pa- patients (Fig. IC). All 57 irregular segments were con- 
tients in both groups. The mean increase in the heart stricted by -8.9 2 5.2% in response to cold pressor testing. 
Table 1. Systemic Hemodynamics During Cold 
Pressor Stimulation 
Control CPT NTG 
Group I (control subjects 
[n = 321) 
Heart rate (beatslmin) 81.1 k 9.8 88.0 + 10.8’ 83.2 r 9.1 
Systolic BP (mm Hg) 119 * 15.8 153.9 t 25.6’ 114.1 + 17.3 
Rate-pressure product 9.67 + 1.9 13.6 * 2.9* 9.53 r 2.6 
Group II (patients with CAD 
[n = 551) 
Heart rate (beatslmin) 72.5 ? 13.8 81.1 + 15.3* 75.3 t 14.8 
Systolic BP (mm Hg) 133.2 + 24.3 166.3 + 27.8* 127.1 + 27.3 
Rate-pressure product 9.69 + 3.1 13.7 + 4.2* 9.48 2 3.9 
*p < 0.01 cold pressor test (CF’T) vs. control. Data are expressed as mean 
values f SD. BP = blood pressure; CAD = coronary artery disease; NTG = 
nitroglycerin; Rate-pressure product = heart rate x systolic blood pressure x 
103; SBP = systolic blood pressure. 
rate-systolic pressure product was 40.7 + 13.5% in the group 
with normal coronary arteries and 43.2 t 20.8% in the group 
with coronary artery disease. Thus, the systemic hemody- 
namics in response to the cold pressor test did not demon- 
strate any significant differences between groups I and II. 
Response of Epicardial Coronary Arteries to 
Cold Pressor Test (Fig. 1) 
Group I: Subjects with normal coronary arteries (Fig. 1A). 
Seventy-seven segments of angiographically normal coro- 
nary arteries were analyzed in the 32 subjects. All 77 
segments dilated by 8.9 + 5.7% in response to the cold 
pressor test. The mean vessel diameter increased from 
2.73 ? 0.14 mm at control study to 2.97 + 0.12 mm (p < 0.01) 
at the end of cold pressor testing. The vasodilating capability 
of all segments was demonstrated by further dilation in 
response to intracoronary nitroglycerin, which increased 
vessel diameter to 3.39 + 0.17 mm (p < O.Ol), reflecting an 
increase of 24.4 of: 12.8% compared with control vessel 
diameter. 
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Normal coronary arteries (N-77) in normal patients (N-32) 
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Stenotii coronary arteries (N=52) 
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Figure 1. Responses of all analyzed coronary artery segments to cold 
pressor testing (CPT) and intracoronary nitroglycerin (NTG) in all 
patients. A, Normal coronary segments in 32 patients. B, Stenotic 
coronary segments in 38 patients with coronary artery disease (>50% 
diameter narrowing). C, Coronary segments with minor luminal 
irregularities in 35 patients with coronary artery disease (17 patients 
with luminal irregularities [<50% diameter narrowing] only, 14 pa- 
tients with one vessel disease and 4 patients with two vessel disease 
but luminal irregularities in other vessels). D, Normal coronary 
segments in 31 patients with coronary artery disease (CAD) in other 
vessels (14 patients with luminal irregularities, 13 patients with one 
vessel disease and 4 patients with two vessel disease). 
The mean vessel diameter decreased from 1.89 k 0.18 mm at 
control study to 1.72 2 0.19 at the end of cold pressor testing 
(p < 0.01). Intracoronary nitroglycerin increased the mean 
vessel diameter to 2.16 2 0.2 mm (p < O.Ol), reflecting an 
increase of 14.2 ~fr 8.6% compared with control values and 
demonstrating the preserved vasodilative capability of these 
irregular segments. 
A total of 47 segments of angiogruphicully normal coro- 
nury arteries u>ere analyzed in the 5.5 group II patients with 
evidence of coronary artery disease elsewhere in the coro- 
nary system (Fig. ID). Only 7 (15%) of the 47 segments were 
dilated in response to sympathetic stimulation, whereas the 
majority of these angiographically normal segments demon- 
strated a paradoxic vasoconstrictor response to the cold 
pressor test despite a completely normal angiographic ap- 
pearance. The mean vessel diameter decreased from 
2.13 2 0.19 mm at control study to 1.98 k 0.21 mm (p < 0.05) 
at the end of cold pressor testing, reflecting a decrease of 
7.0 + 4.9%. lntracoronary nitroglycerin increased the mean 
vessel diameter to 2.52 k 0.22 mm (p < O.Ol), reflecting an 
increase of 18.6 2 11.4% compared with control values and 
demonstrating the vasodilative potential of all measured 
segments. 
Comparison of Responses to Cold Pressor Test 
and Intracoronary Acetylcholine 
Systemic hemodynamics and intracoronary blood flow 
(Table 2). Heart rate and systolic blood pressure increased 
in response to the cold pressor test both in the 9 subjects 
with normal coronary vessels and the 12 patients with 
coronary artery disease. The heart rate-systolic blood pres- 
sure product increased similarly by 39.2 -+ 11.9% in those 
with normal coronary arteries and by 41.3 L 15.8% in the 
group with coronary artery disease. The intracoronary infu- 
sion of acetylcholine had no effect on systemic hemodynam- 
its at the concentrations given in both groups. 
During the cold pressor test, intracoronary blood flow 
velocity within the left anterior descending artery increased 
by 42.3 + 12.7% in subjects with normal coronary arteries 
and by 59. I t 21.3% in patients with coronary artery disease 
(p = NS). 
Comparative responses of epicardial coronary arteries to 
cold pressor test and acetylcholine (Fig. 2). In the group with 
normal coronary arteries, all nine left anterior descending 
artery segments were dilated in response to sympathetic 
stimulation. from 3.1 t 0.23 mm at control study to 3.43 t 
0.25 mm at the end of the cold pressor test (p < O.Ol), 
reflecting an increase of 10.9 I 5.4% (Fig. 2A). After 
baseline values had returned, intracoronary acetylcholine 
caused an increase in diameter of the identical coronary 
artery segments from 3.16 2 0.24 mm at recontrol study to 
3.58 t 0.27 mm at the maximal concentration of 10P6 M 
(p < 0.01). reflecting an increase of 13.3 +- 4.7%. Further 
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Table 2. Systemic Hemodynamics in Response to Cold Pressor Test and Acetylcholine 
Control CPT Recontrol ACh,,, NTG 
Normal subjects (n = 9) 
Heart rate (beatsimin) 79.2 ? 7.3 87.3 2 8.9* 79.9 + 8.1 78.1 2 9.9 80.2 + 10.1 
Systolic BP (mm Hg) 125 + 17.1 157.3 k 23.4* 128.7 + 19.9 126.2 ? 18.7 122.8 L 20.1 
Rate-pressure product 9.85 + 1.9 13.7 k 3.1* 10.1 2 2.3 9.9 f 2.4 9.8 k 3.6 
Patients with CAD (n = 13) 
Heart rate (beatsimin) 74.1 t 11.3 83.2 k 13.8* 75.7 t 12.1 74.6 2 11.4 76.1 k 12.7 
Systolic BP (mm Hg) 135.7 + 21.5 161.8 k 31.2* 138.81 t 28.2 136.6 + 27.8 132.9 k 30.1 
Rate-pressure product 10.0 + 2.9 13.5 t 4.6* 10.5 k 3.4 10.2 k 3.6 10.1 t 4.2 
*p < 0.01 cold pressor test vs. control. Data are expressed as mean values 2 SD. ACh,,, = maximal 
concentration of acetylcholine; other abbreviations as in Table 1. 
vasodilation was obtained by intracoronary nitroglycerin, 
which increased vessel diameter to 3.81 + 0.38 mm (p < 
O.Ol), corresponding to an increase of 22.7 rf: 6.3% compared 
with recontrol values in the study. 
In contrast, in all patients with coronary artery disease, 
including the four patients whose angiograms revealed an 
apparently normal left anterior descending artery with ath- 
erosclerosis in other coronary vessels, the analyzed vessel 
segment of the left anterior descending artery was con- 
stricted in response to sympathetic stimulation. The mean 
diameter decreased from 2.95 ? 0.26 mm at control study to 
2.68 of- 0.28 mm at the end of cold pressor testing (p < O.Ol), 
reflecting a decrease of 9.1 + 3.8% (Fig. 2B). After baseline 
values returned, intracoronary acetylcholine caused a reduc- 
tion in diameter of the identical coronary segments from 2.94 
t 0.28 mm at recontrol study to 2.25 ? 0.36 mm (p < 0.01) 
at the maximal concentration of lo@ M (complete, sponta- 
neously reversible occlusion of the left anterior descending 
artery was encountered in two patients at the maximal 
acetylcholine concentration of lop6 M; therefore, the vessel 
diameters at the 1O-7 M concentration were used in these 
two patients), reflecting a decrease of 23.2 +- 10.4%. The 
vasodilative capability of all analyzed segments was demon- 
strated by the response to intracoronary nitroglycerin, which 
increased vessel diameter in all segments to 3.31 t 0.39 mm 
(p < O.Ol), reflecting an increase of 12.5 + 6.3% compared 
with recontrol values. Thus, the response to sympathetic 
stimulation of the cold pressor test exactly mimicked the 
effects of the endothelium-dependent vasodilator acetylcho- 
line. 
Cold pressor test-induced directional changes in coronary 
blood flow were estimated with use of the Doppler-derived 
mean coronary blood flow velocity and the computed vessel 
cross-sectional area as a rough estimate of blood flow within 
the left anterior descending artery. In all nine subjects with 
normal coronary arteries, mean left anterior descending 
artery blood flow increased by 66 ? 22% during sympathetic 
stimulation. Similarly, in the 13 patients with coronary 
artery disease, blood flow increased by 38 2 31% (p = NS 
versus group I) in response to the cold pressor test. 
Responses to Cold Pressor Test Before and 
After Beta-Adrenergic Blockade 
Systemic hemodynamics and intracoronary blood flow ve- 
locities (Table 3). After the administration of intracoronary 
propranolol, there was essentially no change in systemic 
hemodynamics. A similar pressor response to the cold 
pressor test (both before and after beta-blockade) was ob- 
served, with an increase in the heart rate-systolic blood 
pressure product of 40 + 19% before and 39 2 20% after 
Figure 2. Responses in identical left anterior descending coronary 
artery segments to cold pressor testing (CPT), intracoronary acetyl- 
choline infusion and after nitroglycerin (NTG). A, 9 patients with 
normal coronary arteries. B, 13 patients with coronary artery 
disease. ACh,,, = maximally achieved intracoronary acetylcholine 
concentration ( 10m6 M); C, = control; C, = recontrol. 
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Table 3. Systemic Hemodynamics in Response to Cold Pressor Test Before and After Beta-Blockade 
Pre-Beta Beta- Post-Beta 
Control CPT Recontrol blockade CPT NTG 
Normal subjects (n = II) 
Heart rate (beats/mini 78.4 ? 9.9 86.4 ? lO.6* 80.1 + IO.1 71.9 * 9.7 84.62 ll.I* 80.4 + II.3 
Systolic BP (mm Hg) 126 2 15.7 161 ? 23* 129 ? 17.2 124 f 21 I57 i 25.6* 121 + 21.1 
Rate-pressure product 9.8 2 2.0 13.9 ? 2.6* IO.1 ? 2.2 9.7 * I.9 13.4 ? 2.4’ 9.6 2 2.3 
Patients with CAD (n = 8) 
Heart rate (beats/mm) 70.1 2 7.2 82.2 2 8.8* 70.3 + 8.3 71.2 + 5.7 83.6 ? 7.9* 72.1 2 9.1 
Systolic BP (mm Hg) 147 2 13.7 I82 + 30.1% I42 + 17.9 140 + 18.2 173 ? 21.5* 143 ? 25.1 
Rate-pressure product 10.2 + 1.7 14.9 c 2.5* 9.8 ? 1.9 10.1 ? 2.1 14.5 + 2.65% 9.8 ? 2.8 
*p < 0.01 cold pressor test vs. control, Data are expressed as mean ? SD. Pre-Beta CPT = cold pressor test before beta-adrenergic blockade; Post-Beta 
CPT = cold pressor test after beta-adrenergic blockade; other abbreviations as in Table I. 
beta-blockade in the group with normal coronary arteries, 
and of 48 +- 24% before and 42 ? 25% after beta-blockade in 
the patients with coronary artery disease. 
Mean intracovonary blood flow did not significantly 
change after intracoronary beta-blockade in the patients 
studied by Doppler ultrasound (four with normal coronary 
arteries and five with coronary artery disease). Moreover, 
there was a similar increase in coronary blood flow of 57 t 
17% and 51 ? 21%, respectively, during the pre- and 
postbeta-blockade cold pressor test. 
Responses of epicardial coronary arteries to cold pressor 
test after beta-blockade (Fig. 3). In the group with normal 
coronary arteries (Fig. 3A), all 11 left anterior descending 
artery segments were dilated by 11.3 2 4.4% (from a mean 
control diameter of 3.09 2 0.17 mm to 3.40 5 0.26 mm) (p < 
O.Ol), in response to the first cold pressor test. After baseline 
values returned, intracoronary propranolol did not induce 
any significant changes in vessel diameter. All identical 
coronary segments were again dilated by 8.6 t 4.3% (from 
3.16 t 0.21 mm to 3.37 ? 0.20 mm) (p < 0.01) in response to 
the second cold pressor test during beta-blockade. In no 
instance did we observe a reversal of a vasodilative response 
before beta-blockade to a vasoconstrictor response after 
beta-blockade. 
In the eight putients with coronary artery disease (Fig. 
3B), all measured vessel segments were constricted by 
11.4 ? 4.6% and 14.6 ? S.3%, respectively, during both 
the pre- and post-beta-blockade cold pressor testing. Cold 
pressor test-induced vasoconstrictor responses were not 
significantly different before and after beta-blockade. Thus, 
intracoronary beta-blockade leaving alpha-adrenergic mech- 
anisms unopposed did not significantly affect the vasomotor 
response to sympathetic stimulation in normal or atheroscle- 
rotic coronary arteries. 
Discussion 
Our results indicate that the normal response to sympa- 
thetic stimulation by cold pressor testing in humans is 
coronary vasodilation in patients with normal coronary 
arteries, but paradoxic vasoconstriction in atherosclerotic 
coronary arteries even at a very early stage of coronary 
artery disease. Coronary vasomotion in response to sympa- 
thetic stimulation exactly mirrored the effects of the endo- 
thelium-dependent vasodilator acetylcholine. Endothelial 
dysfunction in coronary atherosclerosis resulted in a loss of 
the normal dilator function and permitted vasoconstrictor 
Figure 3. Responses of coronary artery segments to cold pressor 
testing (CPT) before and after beta-adrenergic blockade by intracor- 
onary (i.c.) propranolol (arrow) and after nitroglycerin (NTG). A, 11 
patients with normal coronary arteries. B, 8 patients with coronary 
artery disease. C, = control; C, = recontrol; C3 = control after 
propranolol; CPT,,, and CPT,,,, = before and after cold pressor 
testing after propranolol. 
. 
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responses to sympathetic stimulation. These results suggest 
that coronary vasomotion in response to cold pressor testing 
in humans is intimately related to the integrity of endothelial 
function. 
Response to sympathetic stimulation. Vasodilation of nor- 
mal coronary arteries and the paradoxic vasoconstriction of 
atherosclerotic coronary arteries in response to sympathetic 
stimulation by cold pressor testing confirm the observations 
recently reported by Nabel et al. (8). However, the para- 
doxic vasoconstrictor response of angiographically “nor- 
mal”-appearing coronary arteries in patients with evidence 
of atherosclerosis elsewhere in the coronary system con- 
trasts with their report (8) of a vasodilative response in 
angiographically smooth regions, even in coronary vessels 
with stenosis and luminal irregularities in other segments. 
Intraoperative echocardiographic studies (11) have dem- 
onstrated that in vivo coronary artery atherosclerosis is far 
more extensive than that predicted by coronary angiogra- 
phy. Coronary artery segments without any angiographic 
narrowing in patients with angiographic evidence of coro- 
nary artery disease elsewhere in the coronary system dem- 
onstrated substantial intimal atherosclerosis by high fre- 
quency echocardiography. Thus, no or apparently trivial 
angiographic narrowing can mask severe coronary athero- 
sclerotic disease. 
Thus, it is very likely that the angiographically normal- 
appearing coronary arteries demonstrating a vasoconstrictor 
response to sympathetic stimulation in our study are, in fact, 
in a very early stage of atherosclerosis or may have mainly 
diffuse intimal thickening. This conclusion is particularly 
substantiated by our demonstration (12) of a vasoconstrictor 
response to acetylcholine, indicating the presence of im- 
paired endothelial functional integrity in angiographically 
normal-appearing epicardial coronary artery segments in 
patients with coronary artery disease. 
Endothelium-mediated vasomotion. Young and Vatner (7) 
recently demonstrated the pivotal role of the endothelium in 
mediating vasomotion of canine iliac arteries in response to 
sympathetic stimulation by epinephrine, a mixed alpha- and 
beta-adrenergic agonist. The vasodilator response to epi- 
nephrine in normal arteries was reversed to a vasoconstric- 
tor response after removal of the endothelium. In addition, 
endothelial integrity played an important role in protecting 
against alpha-adrenergic vasoconstriction of large canine 
iliac arteries. 
Our present results extend these experimental observa- 
tions to the human coronary artery system in vivo. The 
response of human coronary arteries to sympathetic stimu- 
lation by the cold pressor test exactly mimicked the response 
to the endothelium-dependent vasodilator acetylcholine. 
Acetylcholine has been demonstrated (13) to be a very 
sensitive indicator of endothelial integrity in porcine coro- 
nary arteries, and may also induce paradoxic vasoconstric- 
tion early in the course of coronary atherosclerosis in 
humans, thereby indicating a defect in endothelial vasodila- 
tor function (12,14). Thus, the results of our study strongly 
suggest that unimpaired, intact endothelial function is a 
major determinant of vasodilation of human coronary arter- 
ies in vivo in response to sympathetic stimulation by cold 
pressor testing. 
Mechanisms of endothelium-mediated vasomotion. The 
mechanism by which the functional integrity of the endothe- 
hum mediates coronary vasodilation in response to sympa- 
thetic stimulation in humans remains to be determined. 
Recent experimental findings (15) indicate that increases in 
shear stress on endothelial cells inhibit the adrenergic neu- 
rogenic vasoconstriction of rabbit carotid arteries by aug- 
menting the release of endothelial cell-derived vasodilators. 
Coronary blood flow increased significantly during the cold 
pressor test in both groups of patients in our study. Thus, it 
is conceivable that metabolic vasodilation of small arterioles 
resulted in increased flow throughout the vascular bed and 
led to flow-mediated release of endothelium-derived relaxing 
factor (16,17). We have recently demonstrated (18) that there 
is considerable flow-mediated vasodilation of normal human 
coronary arteries in vivo. 
Moreover, recent experimental observations suggest that 
acetylcholine generates an endothelium-derived hyperpolar- 
izing factor (19,20), which is different from endothelial- 
derived relaxing factor, believed to be nitric oxide (21). 
Similarly, a potassium-selective ionic current activated by 
shear stress has been shown to cause endothelial cell hyper- 
polarization (22). It is conceivable that the observed vasodi- 
lation in response to sympathetic stimulation is mediated by 
increased shear stress due to increased coronary blood flow 
and driving pressure during the cold pressor test causing 
endothelial cell hyperpolarization. 
Thus, although the underlying mechanisms of endotheli- 
urn-mediated vasodilation might be different for acetylcho- 
line and sympathetic stimulation, the endothelium appears to 
be the common mediator for vasodilation in response to both 
stimuli. 
Role of interaction between platelets and epithelium. Con- 
sequently, several potential mechanisms may explain the 
reversal of the vasodilator response of normal coronary 
arteries to the vasoconstrictor response of human coronary 
vessels with impaired endothelial function during sympa- 
thetic stimulation. By mediating vasodilation in response to 
cold pressor test-induced increases in driving pressure and 
flow, possibly through the signal of shear stress on the 
endothelium, endothelium-derived relaxing factor (or fac- 
tors) would provide a flow-related dilator feedback to oppose 
the constrictor feedback of the myogenic response to in- 
creased intraluminal pressure. If the endothelium is dysfunc- 
tional because of disease, sympathetic vasoconstriction 
might be augmented. In addition, if in intact vessels the 
endothelium releases endothelial cell-derived vasodilators, 
which oppose the action of all vasoconstrictors, endothelial 
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dysfunction would then cause a nonspecific enhancement of 
the response to all vasoconstrictor stimuli. Therefore, it is 
conceivable that interactions between platelets and the dis- 
eased endothelium may enhance the constrictor responsive- 
ness of the vessel. This could occur by direct sympathetic 
stimulation of platelet alpha-adrenergic receptors to release 
thromboxane, serotonin or histamine (all of which are potent 
vasoconstrictors) or by platelet aggregation and activation at 
the site of endothelial injury. Numerous experimental stud- 
ies (4,6,23,24) have demonstrated that the endothelium pre- 
vents the vasoconstriction induced by aggregating platelets. 
Adrenergic receptor-mediated vasomotion. Stimulation of 
beta-adrenergic receptors in the intact conscious animal has 
been shown (25) to dilate large coronary arteries indepen- 
dent of blood flow-mediated vasodilation. In the present 
study, cold pressor stimulation still elicited coronary vaso- 
dilation after intracoronary beta-blockade in patients with 
normal coronary arteries, indicating that beta-adrenergic 
receptor stimulation is not the major determinant of the 
coronary vasodilator response to sympathetic stimulation. 
In addition, coronary blood flow increased in all patients 
with normal coronary arteries in response to cold pressor 
testing in the presence of beta-blockade. Thus, unopposed 
alpha-adrenergic constriction during sympathetic stimula- 
tion either does not mediate vasoconstriction after beta- 
adrenergic blockade or, more likely, is offset by a metabol- 
ically or flow-dependent endothelium-mediated mechanism, 
or both. Consistent with these findings are those of Gaglione 
et al. (26), who demonstrated that intracoronary propranolol 
does not modify the significant vasodilative response of 
normal coronary arteries to dynamic exercise in humans. 
These results are also in agreement with numerous experi- 
mental studies (27-29) demonstrating that, in normal coro- 
nary arteries, sympathetic stimulation does not reduce 
coronary blood flow after beta-adrenergic blockade, but 
alpha-receptor-mediated coronary vasoconstriction com- 
petes with local metabolic and flow-dependent vasodilation 
secondary to increased metabolic demands. Moreover, it 
was recently shown (30) that norepinephrine-induced relax- 
ation of porcine coronary microvessels is mediated by both 
beta-adrenergic receptors and release of endothelium- 
derived relaxing factor (or factors), whereas only minimal 
alpha-adrenergic-mediated constriction of porcine coronary 
microvessels was noted. 
A dose of 1 mg of propranolol was chosen on the basis of 
previous studies (8,26) using intracoronary propranolol for 
local beta-adrenergic blockade. This dose delivers a drug 
concentration to the left coronary artery in excess of that 
known to produce beta-blockade in the myocardium (31). 
Moreover, 1 mg of intracoronary propranolol represents 
approximately 10% of the full systemic dose (0. I mg/kg body 
weight) and has no secondary effects on global hemody- 
namic determinants of myocardial oxygen consumption (26). 
Experimental studies (32) of isolated vessels demon- 
strated alpha,-adrenoceptor (present on the endothelial 
cells)-mediated endothelium-dependent vasorelaxation. Al- 
though the weak vasoconstriction in response to selective 
alpha,-adrenergic stimulation in intact vessels (7,33) did not 
support these findings, this mechanism cannot be ruled out 
in our patients. 
Comparison with previous studies. Our results appear to 
differ from two previously published observations (34,35) in 
humans that propranolol produces a small but significant 
decrease in coronary flow. Kern et al. (35) observed a small 
decrease in coronary flow after intravenous injection of 
propranolol during cold pressor testing and concluded that 
beta-adrenergic blockade potentiated coronary artery vaso- 
constriction, possibly mediated by unopposed alpha- 
adrenergic vasomotor tone, although coronary artery diam- 
eter was not measured. However, the reported decrease in 
coronary blood flow after intravenous beta-adrenergic block- 
ade can easily be explained by secondary effects on myocar- 
dial oxygen consumption, such as a decrease in heart rate 
and contractility (27), and might not be related to changes in 
epicardial coronary vasomotor tone. Indeed, preliminary 
data from Bortone et al. (36) demonstrate opposite effects of 
intracoronary and intravenous beta-blockade on the diame- 
ter of large epicardial coronary arteries in humans. In 
addition, in the study by Kern et al. (3.5) potentiation of 
coronary artery vasoconstriction in response to cold pressor 
testing after beta-adrenergic blockade was observed only in 
the group of patients with significant coronary artery dis- 
ease, whereas no increase in coronary vascular resistance 
was found in patients with normal coronary arteries. 
Conclusions. The functional integrity of the endothelium 
appears to be the major determinant of coronary vasomotion 
in response to the cold pressor test. Endothelial dysfunction 
in coronary atherosclerosis results in a loss of the normal 
dilator function and permits vasoconstrictor responses to 
sympathetic stimulation in human coronary arteries in vivo. 
We thank the nurses and technicians of the Cardiac Catheterization Labora- 
tory at the University of Freiburg for invaluable assistance in the performance 
of this study. 
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